The impact of the 340B Drug Pricing Program on Critical Access Hospitals : evidence from Medicare Part B
Year of publication: |
2023
|
---|---|
Authors: | Han, Dan |
Published in: |
Journal of health economics. - Amsterdam [u.a.] : Elsevier, ISSN 0167-6296, ZDB-ID 625797-5. - Vol. 89.2023, p. 1-30
|
Subject: | 340B | Drug Pricing | Critical Access Hospitals | Cost-based reimbursement | Medicare | Arzneimittel | Pharmaceuticals | Krankenhaus | Hospital | Gesetzliche Krankenversicherung | Public health insurance | Osteuropa | Eastern Europe | Krankenhauskosten | Hospital costs | Gesundheitskosten | Health care costs | Preis | Price |
-
Kazi Sohag, (2023)
-
Differential Mortality, Uncertain Medical Expenses, and the Saving of Elderly Singles
French, Eric, (2006)
-
Differential Mortality, Uncertain Medical Expenses, and the Saving of Elderly Singles
De Nardi, Mariacristina, (2007)
- More ...
-
Schweinsberg, Martin, (2021)
-
The effects of personal taxes and default risk on bond duration
Xie, Yan Alice, (2023)
- More ...